2.Expressions of transcription factor activator protein-2α, estrogen receptor-β and matrixmetalloproteinase-9 in lichen planus lesions
Chinese Journal of Dermatology 2011;44(5):339-342
Objective To determine the expressions of transcription factor activator protein-2α (AP-2α), estrogen receptor-β (ER-β) and matrixmetalloproteinase-9 (MMP-9) in lichen planus (LP) lesions and their significance. Methods Tissue samples were resected from the lesions of 30 patients with LP and normal skin of 30 human controls. An immunohistochemical method using streptavidin-peroxidase (SP) was performed to detect the expression of ER-β and MMP-9, reverse transcription-PCR and Western blot to measure the mRNA and protein expressions of AP-2α, ER-β and MMP-9 in these specimens. Results There was a significant decrease in the mRNA expressions of AP-2α (0.488 ± 0.039 vs. 1.008 ± 0.023, P < 0.01 ) and ER-β (0.365 ± 0.032 vs. 0.998 ± 0.036, P < 0.01), together with an increase in the expression of MMP-9 (1.237 ± 0.027 vs. 0.567 ± 0.015, P< 0.01) in the LP lesions compared with the control specimens; similar results were observed for the protein expressions of AP-2α, ER-β and MMP-9. In LP lesions, the expression of AP-2α was positively correlated with that of ER-β (R = 0.89, P < 0.01), but negatively correlated with that of MMP-9 (r = -0.91, P < 0.01). Conclusions The down-regulation of ER-β expression and up-regulation of MMP-9 expression may be ascribed to the abnormal regulation of upstream target genes mediated by the decreased expression of AP-2α, which may be involved in the pathogenesis of LP.
3.Role of centrosome in tumorigenesis and oncotherapy
Basic & Clinical Medicine 2010;30(4):431-433
The centrosome plays a crucial role in the maintaining of cell conformation,mitosis and chromosome seg-regation.It responds to the DNA damage and keeps the genome stability via cross-talking with the intranuclear DNA damage repair system.The apoptosis of tumor cells can be induced through inhibition of the duplication of centro-some.So the inhibitors of centrosomal proteins will be a potential anti-tumor therapy.
4.Using Shenghua decoction though syndrome differentiation following childbirth
China Journal of Traditional Chinese Medicine and Pharmacy 2006;0(09):-
Shenghua decoction made by FU Qing-zhu is a famous formula aimed at syndrome of coagulation cold due to blood deficiency,static blood obstruction.The mechanism of disease is definite when this formula is applied.But the extensive use of Shenghua decoction,especially some potent preparation of it following childbirth without according to TCM principle based on differentiation of syndromes is a manifestation of highlighting formula and underestimating theory,which is useless and harmful.It should be emphasized.So the Shenghua decoction should be used under the direction of basic theory of TCM,through precise syndrome differentiation,according to the principle of "looking to and not being besieged by postpartum ".We should not follow blindly the method of treatment of "warming and resolving stasis" on the postpartum disease.It is important that Shenghua decoction should be used on the basis of syndrome differentiation.
5.Study on the TCM sydrome spectra of hemopathy
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(10):-
The study process of TCM syndrome spectra of hemopathy is the process to recognize the syndrome characteristics of the onset, development of hemopathy, it bases on norm of TCM symptoms and syndrome. In this course, it could not only find common feature of syndrome,but also analyze distribution regularity of TCM syndrome. Thus to establish sequence of hemopathic syndrome, and to provide the basis for clinic determination of treatment based on syndrome differentiation, and provide the foundation for finding correlation of TCM syndrome and target tests.
6.MICRO-VASCULAR STRUCTURE OF THE SKIN AND SUPERFICIAL AND DEEP FASCIA IN THE MEDIAL PART OF FOOT UNDER SCANNING ELECTRON MICROSCOPE
Acta Anatomica Sinica 1954;0(02):-
The fresh cadavers were injected with A. B. S into the popliteal arteries. We have studied the micro-vascular structure of this skin area under scanning electron microscope. There are 5 layers of the vascular network in this skin area. They were formed by the small branches coming from either the direct or indirect cutaneous arteries. The 5 layers are as follows: The capillary network of the papillary layer. The vascular network of the subpapillary layer. The deep dermal network. The network in the subcutaneous tissue. The network in the deep fascia tissue. It is clear that each layer of the vascular network has it's -own special character.
7.SCANNING ELECTRON MICROSCOPE STUDIES OF THE MICROCIRCULATION IN THE NAIL BED OF THE TOE
Acta Anatomica Sinica 1954;0(02):-
The vascular morphological character of the microcirculation in the nail bed of the toe have been studied with the scanning electron microscope. Three types of vascular network were identified: 1) The blood vessels at the proximal two fifth of the nail bed were parallelly arranged. 2) At the middle two fifths of the nail bed, the blood vessels interwoved with each other and formed the polygonal vascular networks. 3) At the distal one fifth of the nail bed there were only a few vascular loops running in a slanting position. These loops were connected with the vascular network from the papillary layer of the skin of the toe.
8.CHANGES OF ? ADRENERGIC RECEPTORS AND ANGIOTENSIN Ⅱ RECEPTORS IN SPONTANEOUSLY HYPERTENSIVE RATS AND DIFFERENT AGES WKY RAT HEARTS
Medical Journal of Chinese People's Liberation Army 1981;0(06):-
To study the changes of ? adrenergic receptor subtypes (? 1 AR,? 2 AR) and angiotensin Ⅱreceptor subtypes (AT 1 R,AT 2 R)mRNA levels in spontaneously hypertensive rat (SHR) hearts at 14 weeks of age, and WKY rat hearts at ages 14 and 48 weeks, the total cellular RNA was extracted from the left ventricular tissue, and reverse polymerase chain reaction analysis was performed for measurement of the four receptors. The expression levels of ? 1 AR mRNA and ? 2 AR mRNA were down regulated in WKY hearts at age 48 weeks and in 14 week SHR. AT 1 R mRNA levels were decreased in 48 week WKY and 14 SHR, and AT 2 R mRNA levels were significantly increased in SHR. The expression levels of ? 1 AR and AT 1 R mRNA were declined following the increase of ages. The levels of ? 2 AR mRNA were down regulated in hypertension and myocardial hypertrophy conditions first because ? 2 AR was more sensitive to myocardial hypertrophy than ? 1 AR. Long term and hyper AngⅡ levels stimulated AT 1 R mRNA down regulation in SHR, and it is the myocardial hypertrophic compensatory process that increases the AT 2 R mRNA levels.
9.Tongue Research Overview
Journal of Zhejiang Chinese Medical University 2013;(11):1363-1366,1367
[Objective] To understand Chinese scholars in different periods on the different understanding of tongue, for further development of research and provide a theoretical basis. [Method] Access to a large number of ancient books and literature, selection and tongue of related articles, extract and summa-rize the main points. [Result] The ancient understanding of TCM tongue is very knowledgeable, and by the subjective leading generation, does not have the scientific rigour;modern research of Chinese medicine tongue is mainly from the tongue and tongue color, tongue shape and other aspects, the objec-tive diagnosis and analysis system, the research methods of modern TCM tongue with scientific rigor modern Chinese Medicine; from the point of view, different degrees of col aterals and the width of the color purple tongue, sublingual y reflect the progress of the blood stasis degree and disease conditions, different diseases have different characteristics of the tongue. [Conclusion] Research on the development of modern tongue made certain contribution to TCM development.
10.Progression and challenge of therapeutic strategies in neovascular age-related macular degeneration
Chinese Journal of Ocular Fundus Diseases 2016;32(1):3-7
Choroidal neovascularization (CNV) is the key characteristic of neovascular age-related macular degeneration (nAMD),and the effective therapy is intravitreal injection of anti vascular endothelial growth factor (VEGF) agents based on clinical and basic research.In the meantime the challenge is how to further improve the inhibiting effect for CNV and visual function of anti-VEGF treatment on nAMD.The new strategy and drug delivery devices for anti-VEGF treatment will optimize the clinical scheme.From bench to bedside,the research on targeted treatment of angiogenesis brings the bloom of nAMD medical therapy.